Decision spine
Frames the controlling thesis, evidence status, buyer implications, and research-use limits.
Emerging Med Tech
Zemi Dossier
Research-use only
Perfusable Vascular Networks
A decision package on vascularization as the binding constraint for clinical-grade liver, kidney, and complex tissue biofabrication.
Decision this dossier helps answer
Which biofabrication programs have moved from structural vascular patterns to perfusable, mature, functional integration evidence?
Problem this dossier solves
No vascular integration, no organ-scale product.
The dossier treats perfusable vascular networks as the rate-limiting bridge between elegant constructs and functional tissue. It asks whether flow, maturation, barrier function, and integration are decision-grade or only visually persuasive.
What is moving: current field evidence and platform activity
What is unresolved: decision-grade proof, endpoint logic, and failure modes
What Zemi solves: evidence-gated next-study strategy
Full decision package
107-page research report plus 38-sheet Evidence & Decision Workbook
Buy now
$3,500$5,500Launch price
Controlling thesis
No vascular integration, no organ-scale product.
The dossier treats perfusable vascular networks as the rate-limiting bridge between elegant constructs and functional tissue. It asks whether flow, maturation, barrier function, and integration are decision-grade or only visually persuasive.
A Zemi Dossier turns uncertain emerging research into a decision package: what is known, what is inferred, what is hypothetical, what would falsify the thesis, and what should be built, funded, avoided, monitored, or validated next.
Research report preview
First 30 pages of the actual Perfusable Vascular Networks research report.
The public page shows the real document style, density, evidence posture, and decision framing before a buyer requests access to the full Zemi Dossier package.
Research report
The research report is the argument. It is not the whole product.
The PDF research report is the structured argument: field status, evidence maturity, buyer implications, falsifiable hypotheses, power-calculated next studies, strategic recommendations, limitations, and traceability posture.
Inspectable infrastructure
Pairs the report with claim ledgers, evidence tables, power rows, audit surfaces, and decision tools.
Executable next studies
Links hypotheses to endpoint logic, assumptions, sample-size logic, budget, and timeline planning.
Research report table of contents
Public TOC generated from the source report.
The full research report is delivered as a licensed PDF. This table shows the decision structure without publishing the full product.
| Section | What it covers | Buyer value |
|---|---|---|
| 1. Decision Brief: Read This First {#decision-brief} | Turns the report into immediate buyer triage: what matters now, what is still uncertain, and what to do next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 2. Executive Summary {#executive-summary} | Condenses the dossier thesis, evidence posture, buyer implications, and next-study priorities. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 3.1 The intellectual spine, stated plainly | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 3.2 Why the conservative reading is the correct reading | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 3.3 The arbitrage, stated for the buyer | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 3. Report Scope and Evidence Integrity Statement {#scope} | Defines the evidence window, source boundaries, research-use limits, and labeling discipline. | Lets the buyer audit support strength before relying on the package. |
| 1.1 Scope | Defines the evidence window, source boundaries, research-use limits, and labeling discipline. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 1.2 Evidence integrity | Defines the evidence window, source boundaries, research-use limits, and labeling discipline. | Lets the buyer audit support strength before relying on the package. |
| 1.3 Claim boundary (what this report does and does not assert) | Defines the evidence window, source boundaries, research-use limits, and labeling discipline. | Lets the buyer audit support strength before relying on the package. |
| 1.4 Claim-language discipline | Links claims to source support so users can separate what is known, inferred, and hypothetical. | Lets the buyer audit support strength before relying on the package. |
| 1.5 Who should use this dossier | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 1.6 What this report is — and is not | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 4. 2026 Current-Signal Refresh {#signal-update} | Frames the field's June 2026 state, active programs, research fronts, and timing signals. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 5. The Borrowed-Perfusion Ledger — Controlling Model {#ledger} | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 5.1 The seven coupled gates | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| 5.2 Why a minimum, not a sum | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 5.3 The binding gate is organ-specific | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| 5.4 What the model changes, and what would falsify it | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 5.5 Gate-by-gate: where each subsidy is largest | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| 5.6 Why the gates cannot be traded against one another | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| 5.7 Quantifying the borrowed-perfusion ceiling | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 5.8 Why a bottleneck model fits this field specifically | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 5.9 The Perfusion Autonomy Index (PAI) — making "borrowed vs built" measurable | Operationalizes the thesis as a reusable decision surface for comparing programs or evidence states. | Gives the buyer a reusable way to compare programs, risks, and evidence states. |
| 5.10 The Perfusion Autonomy Spectrum — why the most-borrowed approaches win first | Defines the governing argument and the evidence gates that would support or falsify it. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 6. Decision Snapshot {#decision-snapshot} | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 6.1 Reading the snapshot against the milestone calendar | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 7. Buy / Build / Wait / Avoid + Buyer Decision Dashboard {#buyer-cheat-sheet} | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| GO | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| CONDITIONAL GO | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| WATCH | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| NO-GO (until disproven) | Maps findings to buyer actions: build, fund, avoid, monitor, or validate next. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 7.1 The logic beneath the four verdicts | Links claims to source support so users can separate what is known, inferred, and hypothetical. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 7.2 The evidence behind each verdict, and the limitation each carries | Links claims to source support so users can separate what is known, inferred, and hypothetical. | Lets the buyer audit support strength before relying on the package. |
| 8. Source Quality Dashboard {#source-quality} | Shows how strong the source base is and where conclusions depend on indirect or thinner support. | Lets the buyer audit support strength before relying on the package. |
| 8.1 Reading the dashboard honestly | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
| 8.2 Why a conservative grade distribution is a feature | Summarizes a report component that ties field evidence to the dossier's decision logic. | Helps the buyer inspect the argument, evidence posture, and decision logic before relying on the package. |
Evidence & Decision Workbook
The workbook is the decision engine.
A locked public preview of selected workbook-derived sheets: sheet structure, decision modules, power rows, traceability, and audit posture. Licensed buyers receive the full workbook files.
Read-only workbook preview with clipped values and no formulas. Licensed buyers receive the full Evidence & Decision Workbook with editable assumptions and working files.
Workbook inventory
Delivered workbook sheets.
Full inventories belong on dossier pages, not the homepage. Sheet names below are extracted from the actual workbook file.
| # | Workbook sheet | What it does |
|---|---|---|
| 1 | 1. Workbook Guide | Navigation layer for using the workbook, understanding sheet roles, and following the decision package. Public preview exposes Sheet, Purpose, How to use it fields and clipped entries such as 2. Claim Ledger, 68 customer-facing claims with full., Filter by. |
| 2 | 2. Claim Ledger | Claim-by-claim ledger showing verdicts, source support, inference status, and decision relevance. Public preview exposes claim_id, claim_text, report_section, page fields and clipped entries such as CL-01, Hepatic organoids recapitulate key., Key Findings &. |
| 3 | 3. Evidence Table | Evidence-verification surface for checking sources, support quality, and the audit trail. Public preview exposes source_id, identifier, authors, year fields and clipped entries such as S01, DOI:10.1038/s41551-025-01416-6, Saiki N, Nio Y, Yoneyama Y, et al.. |
| 4 | 4. Source Support Verdicts | Independent check on whether key claims are actually supported by cited sources. Public preview exposes claim_id, source_id, verdict, directness fields and clipped entries such as CL-01, PMID:40615111, SUPPORTS_PARTIALLY. |
| 5 | 5. Source Quality Summary | Summary of source strength, gaps, and areas where conclusions depend on weaker evidence. Public preview exposes Total claims audited (source pack), 179, Full Claim Audit row count fields and clipped entries such as Kept (customer-facing, base), Eligible for. |
| 6 | 6. Platform Scorecard | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes platform, primary_sources, Peer-reviewed evidence, Large-animal relevance fields and clipped entries such as Liver bud sinusoidal. |
| 7 | 7. Liver vs Kidney | Workbook surface supporting a specific evidence, decision, study-planning, or release-control workflow. Public preview exposes Strongest functional evidence, Clotting-factor rescue; ALF., Engraftment in porcine NMP ≤ 48 h. fields and clipped entries such as. |
| 8 | 8. Figure Source Map | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes figure_id, title, family, section_anchor fields and clipped entries such as FIG-01, Evidence Maturity Heat Map, evidence_maturity_heat_map. |
| 9 | 9. Figure Attempt Ledger | Figure and numeric reproduction log for validating calculations, chart inputs, or displayed values. Public preview exposes figure_id, figure_title, figure_family, figure_type fields and clipped entries such as FIG-01, Evidence Maturity Heat Map,. |
| 10 | 10. Next Studies | Prioritizes next studies that could change the decision, including endpoints and evidence gates. Public preview exposes id, title, research_question, model fields and clipped entries such as NS-01, Temporary liver-support large-animal., Does a. |
| 11 | 11. Validation Gates | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes gate_id, organ, gate, validation_criteria fields and clipped entries such as G1, Liver, Temporary liver-support construct.. |
| 12 | 12. CMC Risk Matrix | Captures failure modes and constraints that could invalidate or narrow a program. Public preview exposes platform, Xeno-free materials, Defined media, Cell source defined fields and clipped entries such as Liver bud sinusoidal self-organization, Vascularized. |
| 13 | 13. Regulatory Tracker | Tracks regulatory, endpoint, reimbursement, or qualification requirements that shape testing strategy. Public preview exposes Topic, Requirement / Status, Maturity, Note fields and clipped entries such as Product classification, Biologic vs device vs. |
| 14 | 14. Company-Funding Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes entity, type, organ_focus, signal fields and clipped entries such as Carnegie Mellon University (FRESH /., Academic + ARPA-H performer, Liver. |
| 15 | 15. Trial-Registry Tracker | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes identifier, title, type, phase/status fields and clipped entries such as (none found), Bioprinted/organoid liver or kidney., Interventional. |
| 16 | 16. 2026 Update Sources | Monitoring surface for emerging signals, update triggers, and evidence changes that could alter the decision. Public preview exposes id, source, claim, verification_status fields and clipped entries such as X01, ARPA-H Award Directory (Award 3626,., ARPA-H. |
| 17 | 17. Internal Audit & Validation | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes Audit roles, Evidence synthesizer, critical. fields and clipped entries such as Evidence window, Late 2025 through mid-2026, with a.,. |
| 18 | 18. Hypotheses Ledger | Maps hypotheses to evidence state, falsification logic, endpoints, and next-study design. Public preview exposes id, tier, paradigm, title fields and clipped entries such as F1, Flagship, Host-vs-construct perfusion.. |
| 19 | 19. Power Calculations | Power-calculation layer for assumptions, endpoint logic, computed sample sizes, and sensitivity checks. Public preview exposes hypothesis_id, study_id, endpoint, test_type fields and clipped entries such as F1, F1-S, Construct-derived fraction of.. |
| 20 | 20. Competitive Landscape | Tracks programs, trials, sponsors, or competitive context for diligence and monitoring. Public preview exposes company / performer, asset / platform, modality, target (organ) fields and clipped entries such as Carnegie Mellon (LIVE), FRESH + 3D-ice;. |
| 21 | 21. Score Basis | Explains how scores or ratings were assigned so the decision instrument can be inspected. Public preview exposes fig01 evidence maturity, 0-4 (none..robust), Per platform x dimension; cited. fields and clipped entries such as fig03 platform matrix, 0-4. |
| 22 | 22. Traceability Certificate | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes #, claim_id, report_section/page, claim_text fields and clipped entries such as CL-01, § Key Findings & Data Analysis, Hepatic organoids. |
| 23 | 23. Version Registry | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes Evidence cutoff, 2026-06-13, Fresh scan: 67 logged queries; 20., - fields and clipped entries such as Next update trigger, H2. |
| 24 | 24. Audit Issues Log | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes #, Issue, Status, Resolution fields and clipped entries such as AI-1, Workbook genuinely executable?, RESOLVED. |
| 25 | 25. Verification & Search Log | Release-discipline surface for revisions, unresolved issues, audit findings, and readiness tracking. Public preview exposes #, Source / DB, Query, Hits fields and clipped entries such as pubmed, bioprinted liver vascularization AND., pubmed. |
| 26 | 26. Near-Discovery Watch | Monitoring surface for emerging signals, update triggers, and evidence changes that could alter the decision. Public preview exposes ND-1, Lineage-traced host-vs-construct., Would settle whether constructs., No mammalian lineage-tracing. fields and clipped. |
| 27 | 27. Cross-Domain Synthesis | Workbook surface supporting a specific evidence, decision, study-planning, or release-control workflow. Public preview exposes id, synthesis claim, what it connects, claim IDs fields and clipped entries such as XS-1, The host is doing the work (across.,. |
| 28 | 28. Expert Objections | Captures failure modes and constraints that could invalidate or narrow a program. Public preview exposes objection, why valid / partial, response (evidence), linked fields and clipped entries such as Host infiltration vs lineage tracing, Without lineage. |
| 29 | PAC_Input_Template | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Evidence completeness, 0-1 (how complete is the evidence., ____ fields from this sheet. |
| 30 | PAC_Feature_Score | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Gate (output class), Meaning (rubric: 3 = severe., Deficit 0-3 (ENTER), Weight (expert-init) fields and clipped entries such as. |
| 31 | PAC_PAI_Index | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Evidence confidence (ENTER 0-1), 0.6 fields from this sheet. |
| 32 | PAC_Class_Output | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Evidence completeness (ENTER 0-1), 0.8 fields and clipped entries such as Organ (ENTER LIVER / KIDNEY / OTHER), LIVER, Archetype (deficits). |
| 33 | PAC_Decision_Rules | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Class (binding gate), Recommended strategy, Primary functional endpoint, Required safety readout fields and clipped entries such as. |
| 34 | PAC_Organ_Rules | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes n/a, OTHER tissue -- apply the generic., Tissue-specific function under., Tissue-specific. fields and clipped entries such as cross-organ, OTHER. |
| 35 | PAC_Minimum_Assay_Panel | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Cross-center CV on primary., Potency, Preferred, Reproducibility for batch release. fields from this sheet. |
| 36 | PAC_Archetype_Cards | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Archetype, Profile (deficits), Binding gate, Organ fields and clipped entries such as Bioprinted liver-support construct., [3,2,2,2,1,2,3],. |
| 37 | PAC_Validation_Log | Executable decision surface for classifying programs, risks, gates, or evidence states. Public preview exposes Calibration requirement, Reliability across >=3. fields and clipped entries such as Functional endpoint, Durable perfusion + organ-specific.,. |
| 38 | PAC_Traceability_Map | Traceability surface linking claims, figures, calculations, and workbook outputs back to sources. Public preview exposes PAC element, Maps to claim/finding, Evidence ID, Figure fields and clipped entries such as Host-Drive Internalization, convergent. |
Power-calculated next studies
Power calculations are the execution bridge.
Power calculations are planning-grade research calculations for endpoint logic, assumptions, sample size, budget, and timeline. They do not prove hypotheses or constitute clinical protocol.
| Hypothesis | Primary endpoint | Test | Effect | α | Power | Computed n | Design n |
|---|---|---|---|---|---|---|---|
| F1 | Construct-derived fraction of FLOW-BEARING luminal end | Two-proportion | 0.3 | 0.05 | 0.80 | 93 | 96 |
| F2 | Durable perfusion-days under construct-intrinsic drive | Two-sample t | 0.7 | 0.05 | 0.80 | 33 | 36 |
| F3 | Functional output per unit perfused vascular volume (c | Two-sample t | 0.8 | 0.05 | 0.80 | 25 | 28 |
| F4 | Obstructive-injury rate (intratubular pressure > thres | Two-proportion | 0.6 | 0.05 | 0.80 | 23 | 28 |
| F5 | Graft survival at 30 days | Two-proportion | 0.55 | 0.05 | 0.80 | 61 | 64 |
Release audit discipline
Audit posture is part of the product.
Public pages do not publish exact audit scores. They should state the release discipline, revision posture, and limitations without implying peer review or validated clinical guidance.
Research-use decision package
Not medical advice, clinical guidance, investment advice, or a clinical protocol.
Known / inferred / hypothetical
The package separates cited evidence from inference and frontier hypothesis generation.
Audit-gated and revision-controlled
Adversarial audit checks source support, formulas, figures, limitations, and release readiness.
Buy this dossier
Full decision package — 107-page report + 38-sheet workbook
Buy now
- Decision research report (107 pages, PDF)
- Evidence & Decision Workbook (38 sheets, .xlsx) — claims, source-support verdicts, power calculations, traceability, and audit log
- Live, editable power-calculated next studies
$3,500$5,500Launch price